Vista Pharmaceuticals Ltd.

BSE: 524711	Sector: Health care
NSE: N.A.	ISIN Code: INE427C01021

BSE 00:00 | 24 Jun

7.04

-0.11
(-1.54%)

OPEN

7.40

HIGH

7.40

LOW

6.87

NSE 05:30 | 01 Jan

Vista Pharmaceuticals Ltd

Add to Watchlist | Add to Portfolio

OPEN	7.40
PREVIOUS CLOSE	7.15
VOLUME	27308
52-Week high	15.97
52-Week low	6.51
P/E
Mkt Cap.(Rs cr)	26
Buy Price	0.00
Buy Qty	0.00
Sell Price	0.00
Sell Qty	0.00

OPEN	7.40
CLOSE	7.15
VOLUME	27308
52-Week high	15.97
52-Week low	6.51
P/E
Mkt Cap.(Rs cr)	26
Buy Price	0.00
Buy Qty	0.00
Sell Price	0.00
Sell Qty	0.00

Vista Pharmaceuticals Ltd. (VISTAPHARMA) - News Sector

Dr Reddy's Laboratories eyes place among top five domestic pharma players

12.54 am | 25 Jun 2022 | Business Standard

The US would continue to remain an important geography, but the firm says it hopes to double its revenues from China and grow revenues five-fold in Br...
Ajanta Pharma extends fall, slips 2%; stock turned ex-bonus on Wednesday

12.56 pm | 23 Jun 2022 | Business Standard

The company had fixed June 23, 2022 as the record date for the bonus issue in the proportion of one equity share for every two equity shares held
Biocon slips 4% despite arm denying bribery charges

11.07 am | 22 Jun 2022 | Business Standard

At 10:26 AM, the stock of Biocon was down 3 per cent at Rs 316.10, as compared to 1 per cent decline in the S&P BSE Sensex
Gland Pharma rides high on valuation comfort, strong growth prospects

12.51 am | 22 Jun 2022 | Business Standard

Target prices post brokerage upgrades point to more upsides
Suven Life freezes at 20% upper circuit as board to mull rights issue

3.23 pm | 21 Jun 2022 | Business Standard

The stock had hit a 52-week low of Rs 62 on June 20, 2022, and has corrected 50 per cent from its record high level of Rs 124 touched on October 8, 20...
Stocks to Watch: Telecom, LIC Hsg Fin, KEC Intl, Suven Life, IIFL Finance

7.56 am | 21 Jun 2022 | Business Standard

Stocks to Watch Today: Indiabulls Housing Finance and RBL Bank are the two stocks in F&O ban period on Tuesday.
1 in 3 Nifty500 stocks are down 25% YTD; 15 have halved their 2022 gains

1.30 pm | 20 Jun 2022 | Business Standard

A total of four stocks -- Dhani Services, Brightcom Group, Indiabulls Real Estate and Solara Active Pharma Sciences -- have been butchered more than 6...
Glenmark drug for treating uncontrolled asthma gets Indian regulator's nod

12.35 am | 17 Jun 2022 | Business Standard

Company says treatment will be affordable and improve lung function of patients
Paytm, Zomato, Indiabulls Housing look oversold; can jump up to 25%

1.08 pm | 15 Jun 2022 | Business Standard

Among the beaten down mid- and small-cap stocks, Paytm and Zomato can provide some relief to investors, while stocks like Metropolis Healthcare and La...
No plans to exit business, says Metropolis Healthcare promoters

11.01 am | 14 Jun 2022 | Business Standard

"The company, its promoters and management team are committed to operating Metropolis Healthcare Ltd with the highest standards of medical science, st...
No plans to exit business, clarify Metropolis Healthcare promoters

10.53 am | 14 Jun 2022 | Business Standard

Metropolis Healthcare is continuously exploring various strategic options and investment
Metropolis tanks 27% in 1-mth on promoter stake sale buzz, latter clarifies

9.59 am | 14 Jun 2022 | Business Standard

The promoters of Metropolis Healthcare on Monday after market hours clarified that they have no intention to exit the business.
Stocks to Watch: Banks, Lupin, YES Bank, CG Electricals, Ujjivan SFB, Sugar

8.19 am | 9 Jun 2022 | Business Standard

Stocks to Watch Today: Sugar industry has requested the government that the additional 1 MT export order be given the mills, and not trader or exporte...
Tamil Nadu agency blacklists Abbott for five years for hiding information

1.07 am | 9 Jun 2022 | Business Standard

TNMSC Managing Director Deepak Jacob said the step was taken after a complaint from Paris Legal Cell in Chennai
Lupin receives tentative approval from USFDA to market Ivacaftor tablets

12.42 am | 9 Jun 2022 | Press Trust of India

The product is the generic equivalent of Vertex Pharmaceuticals' Kalydeco tablets, Lupin said in a statement
Biocon hits over two-year low; slips 18% in six weeks post weak Q4 results

11.55 am | 8 Jun 2022 | Business Standard

In the past one year, the stock has slipped 22 per cent, as against a 39 per cent rally in the S&P BSE Sensex.
Trading strategies for Thyrocare, Dr Lal Path, Metropolis amid Covid scare

11.49 am | 6 Jun 2022 | Business Standard

Thyrocare, Dr Lal Path Labs and Metropolis are trading almost 50 per cent below their respective all-time highs, the reversal may see breakout if the ...
Trading strategies for Thyrocare, Dr Lal Path, Metropolis amid Covid scare

11.49 am | 6 Jun 2022 | Business Standard

Thyrocare, Dr Lal Path Labs and Metropolis are trading almost 50 per cent below their respective all-time highs, the reversal may see breakout if the ...
Trading strategies for Thyrocare, Dr Lal Path, Metropolis amid Covid scare

11.49 am | 6 Jun 2022 | Business Standard

Thyrocare, Dr Lal Path Labs and Metropolis are trading almost 50 per cent below their respective all-time highs, the reversal may see breakout if the ...
Stocks to Watch: M&M, Tata Coffee, Voda Idea, Coal India, Hindalco, REL

7.49 am | 6 Jun 2022 | Business Standard

Stocks to Watch Today: The Aditya Birla Group has planned a massive Rs 77,000 crore capex; Meanwhile, this week the focus will be on rate sensitive se...